Endometriosis linked to adverse pregnancy outcome

Article

Whether women use assistive reproductive technology, women with endometriosis are about 33% more likely than women without the condition to give birth prematurely, according to a nationwide study.

Whether or not women use assisted reproductive technology (ART), women with endometriosis are about 33% more likely than women without the condition to give birth prematurely (adjusted OR, 1.33; 95% CI, 1.23-1.44), according to a nationwide Swedish study. They are also almost twice as likely to require cesarean delivery; 80% more likely to experience antepartal bleeding, including placental disorders; and at greater risk for preeclampsia.

In this study, which included data on more than 1.4 million births, 13,090 singleton births occurred among 8,922 women diagnosed with endometriosis.

Far more women with endometriosis used ART than did women without (11.9% vs 1.4%, respectively).

The authors of the study found no association between endometriosis and small-for-gestational-age birth or stillbirth.

Stephansson O, Kieler H, Granath F, Falconer H. Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod. 2009;24(9):2341-2347.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.